SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 157 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$52,898
-36.0%
17,064
-71.3%
0.00%0.0%
Q1 2023$82,655
-38.5%
59,464
-11.9%
0.00%0.0%
Q4 2022$134,373
-61.7%
67,524
-61.1%
0.00%
-66.7%
Q3 2022$351,000
+73.8%
173,608
+312.4%
0.01%
+20.0%
Q4 2021$202,000
-60.9%
42,100
-56.4%
0.01%
-44.4%
Q3 2021$516,000
+24.3%
96,619
+19.3%
0.01%
+12.5%
Q2 2021$415,000
-40.8%
80,970
-22.3%
0.01%
-33.3%
Q1 2021$701,000
+51.1%
104,175
-12.9%
0.01%
-14.3%
Q3 2020$464,000
-6.5%
119,600
+14.9%
0.01%
-41.7%
Q2 2020$496,000104,1000.02%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders